Bifidobacterium lactis MAK16B42L and Reduced Antibiotic-Associated Diarrhea

• Bifidobacterium animalis subsp. lactis XLTG11 improves antibiotic-related diarrhea by alleviating inflammation, enhancing intestinal barrier function and regulating intestinal flora.

  • 2022-06-08
  • Clinical Trial
  • Food & Function 13(11)
  • • Baofeng Xu
    • Shengnan Liang
    • Jiayi Zhao
    • Xuetong Li
    • Jiayao Guo
    • Bowen Xin
    • Bailiang Li
    • G. Huo
    • Weiwei Ma

  • PubMed: 35616024
  • DOI: 10.1039/d1fo04305f

  29 Insights on

  • Reduced Antibiotic-Associated Diarrhea

  • Low evidence
  • Animal Study
  • Clinical

  B. lactis XLTG11 can promote the recovery of intestinal flora and mucosal barrier function, thereby effectively improving AAD-related symptoms.

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes